Erratum: Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis (PLoS ONE (2014) 9:9 (e108635) DOI: 10.1371/journal.pone.0108635);Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Shirazi, Fazal ^a   Farmakiotis, Dimitrios ^a   Yan, Yuanqing ^a   Albert, Nathaniel ^a   Do, Kim Anh ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; FAT INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DROSOPHILA MELANOGASTER; EXPERIMENTAL MODEL; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MORTALITY; MUCORMYCOSIS; NONHUMAN; OBESITY; PATHOGEN LOAD; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WILD TYPE; ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; FEEDING BEHAVIOR; HUMAN; LIPID DIET; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; RHIZOPUS; SURVIVAL;

ANIMALS; DIET, HIGH-FAT; DIETARY FATS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; FEMALE; FOOD HABITS; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; METFORMIN; MUCORMYCOSIS; OBESITY; RHIZOPUS; SURVIVAL ANALYSIS; TRIGLYCERIDES;

EID: 84907495069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116684     Document Type: Erratum

References (38)

1. Peleg AY, Weerarathna T, McCarthy JS, Davis TME (2007) Common infections in diabetes: pathogenesis, management and relationship to glycemic control. Diabetes Metab Res Rev 23: 3-13.
2. Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. In Berstein LM, Santen RJ, editors. Innovative endocrinology of cancer. Land bioscience and Springer science. Norway, Oslo, pp 72-93.
3. Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E (2004) Improved outcome of zygomycosis in patients with hematological diseases? Leukemia Lymphoma 45: 1351-1360.
4. Foss NT, Foss-Freitas MC, Ferreira MAN, Cardili RN, Barbosa CMC, et al. (2007) Impaired cytokine production by peripheral blood mononuclear cells in type-1 diabetic patients. Diabetes Metab 33: 439-443.
5. Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012) Diabetes and mucormycosis: a complex interplay. Diabetes Metab. 38: 193-204.
6. Kontoyiannis DP, Lewis RE (2006) Invasive zygomycosis: update on pathogenesis, clinical manifestations and management. Infect Dis Clin North Am 20: 581-607.
7. Kontoyiannis DP, Lewis RE (2011) How I treat mucormycosis. Blood 118: 1216-1224.
8. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, et al. (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-60.
9. Hamili RJ (2013) Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 73: 919-934.
10. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, et al. (2008) Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci USA 105: 9367-9372.
11. Hong JW, Park KW (2010) Further understanding of fat biology: Lessons from a fat fly. Exp Mol Med 42: 12-20.
12. Bharucha KN (2009) The Epicurean Fly: Using Drosophila melanogaster to Study Metabolism. Pediatr Res 65: 132-137.
13. Teleman AA, Ratzenbock I, Oldham S (2012) Drosophila: A model for understanding obesity and diabetic complications. Exp Clin Endocrinol Diabetes 120: 184-185.
14. Baker KD, Thummel CS (2007) Diabetic larvae and obese flies-emerging studies of metabolism in Drosophila. Cell Metab 6: 257-266.
15. Falagas ME, Kompoti M (2006) Obesity and infection. Lancet Infect Dis 6: 438-336.
16. Birse RT, Choi J, Reardon K, Rodriguez J, Graham S, et al. (2010) High-Fat-Diet-Induced Obesity and Heart Dysfunction Are Regulated by the TOR Pathway in Drosophila. Cell Metabol 12: 533-544.
17. Heinricksen ET, Haddad GC (2012) Role of high-fat diet in stress response of Drosophila. PLoS One 7: e42587.
18. Slack C, Foley A, Partridge L (2012) Activation of AMPK by the putative dietary restriction mimetic metformin is insufficient to extend lifespan in Drosophila. PLoS One 7: e47699.
19. MacIntyre EJ, Majumdar SR, Gamble JM, Minhas-Sandhu JK, Marrie TJ, et al. (2012) Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia. Am J Med 125: 1036.e17-23.
20. Marik PE, Bellomo R (2013) Stress hyperglycemia: an essential survival response. Crit Care Med 41: e93-94.
21. WHO: The World Health Statistics (2013) Available at: http://www.who.int/gho/publications/world-health-statistics.
22. Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444: 875-880.
23. Kaplan NM (1989) The deadly quartet: Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514-1520.
24. Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Edocrinol Metabol 11: 327-332.
25. Wareham NJ, Byrne Cd, Williams R, Dane NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. Diab Care 22: 262-270.
26. Scheen AJ, Paquot N (2013) Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab 39: 179-190.
27. Colman J, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325: 201-204.
28. Anisimov VN, Berstein LM, Popovich IG, Zabezhinski MA, Egormin PA, et al. (2011) If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging 3: 148-157.
29. Anisimov VN, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, et al. Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging 2: 945-958.
30. Almond MH, Edwards MR, Barclay WS, Johnston SL (2013) Obesity and susceptibility to severe outcomes following respiratory viral infection. Thorax 68: 684-686.
31. Kwong JC, Kampitelli MA, Rosella LC (2011) Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: A cohort study. Clin Infect Dis 53: 413-421.
32. Al-Zahrani MS, Bissada NF, Borawskit EA (2003) Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74: 610 -615.
33. Vilar-Compte D, Mohar A, Sandoval S, de la Rosa M, Gordillo P, et al. (2000) Surgical site infections at the National Cancer Institute in Mexico: a case-control study. Am J Infect Control 28: 14-20.
34. Saliba W, Barnett-Griness O, Rennert G (2013) The association between obesity and urinary tract infection. Eur J Intern Med 24: 127-131.
35. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukaks NW, et al. (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 168: 4018-4024.
36. Plotkin BJ, Paulson D, Chelich A, Jurak D, Cole J, et al. (1996) Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocytes function. J Med Microbiol 44: 277-283.
37. Dionne MS, Pham LN, Shirazu-Hiza MM, Schneider DS (2006) Akt and Foxo dysregulation contribute to infection-induced wasting in Drosophila. Curr Biol 16: 1977-1985.
38. Libert S, Chao Y, Zwiener J, Pletcher SD (2008) Realized immune response is enhanced in long-lived puc and chico mutants but is unaffected by dietary restriction. Mol Immunol 45: 810-817.